BioSig Announces Reverse Stock Split
January 31, 2024 11:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024 08:30 ET
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
Tumor Ablation Market Size to Reach USD 2.3 Billion, at a 6.9% CAGR By 2031 - Transparency Market Research Inc.
December 22, 2023 05:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global tumor ablation market was projected to attain US$ 1.3 billion in 2022. It is...
United States Liver Cancer Therapeutics Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
December 07, 2023 11:08 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "United States Liver Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023 14:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 13, 2023 16:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 09, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to...
Electrophysiology Devices Global Strategic Business Report: Players Include CardioFocus, Medtronic, MicroPort Scientific and Nihon Kohden
November 07, 2023 07:23 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Electrophysiology Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Thyroid Ablation Devices Market to Reach $318.4 Million by 2030: Growing Preference for Minimally Invasive Surgeries Drives the Sector
November 03, 2023 07:03 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Ablation Devices Market Size, Share & Trends Analysis Report By Product (Non-thermal, Thermal), By Application (Cancer, Nodules), By...
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
November 02, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...